Natco Pharma Ltd.

Pharmaceutical company, Natco Pharma, has begun the sale of its first compulsorily licensed drug, which is the generic version of Bayer's Nexavar. The drug, which is used for the treatment of advanced kidney cancer, is priced at Rs 8,880 for a pack of 120 tablets. The company is expecting to add about Rs 15 crore revenue from this drug initially.

In a major blow, Natco Pharma recently lost a patent litigation against Israel's Teva Pharmaceutical Industries in the US over multiple sclerosis treatment drug - Copaxone.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets. The company began its operations in 1984 in Andhra Pradesh.